Active Shortage

JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE

JAMP PHARMA CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE in Canada?

Yes. JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG has an active shortage reported to Health Canada (last updated September 21, 2026).

Why is JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE be available again?

The manufacturer's estimated resolution date is June 30, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Expected resolution~9 months remaining (estimate)

Affected strength600MG 300MG 200MG

Last updated2026-09-21

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2027-06-30

~9 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02519461

Strength

600MG 300MG 200MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

EFAVIRENZ TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE

Tier

Unrated

Last Updated

2026-09-21

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from JAMP PHARMA CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACTIVATED CHARCOAL

225MG · DIN 02420694

AMIKACIN SULFATE INJECTION

250MG · DIN 02529459

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02423227

AMLODIPINE

2.5MG · DIN 02492199

AMLODIPINE

10MG · DIN 02429225

AMLODIPINE

5MG · DIN 02429217